ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #1,498Top JournalHybrid

Frontiers in Immunology

Abbreviation (ISO):FRONT. IMMUNOL
•
Identifier (ISSN):1664-3224(Print)
•
Publisher:Frontiers Media S.A.
Clarivate IF (2026)
7↑ +1.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Frontiers in Immunology

WoS Q1
369125.5120184.7220195.0820207.5620218.7920227.320235.720245.9202572026
Annual Impact Factor Metric
Current (2026):7
Scopus SJR & RankScopus Q1
1.964
#1,498

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
294

294 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate8.8%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
5,759articles/year
99.9% Gold OA•72.57% Original Research

Aims & Scope

Frontiers in Immunology is a leading journal in its field, publishing rigorously peer-reviewed research across basic, translational and clinical immunology. Field Chief Editor Luigi Daniele Notarangelo is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide. Frontiers in Immunology is the official Journal of the International Union of Immunological Societies (IUIS). Encompassing the entire field of Immunology, this journal welcomes papers that investigate basic mechanisms of immune system development and function, with a particular emphasis given to the description of the clinical and immunological phenotype of human immune disorders, and on the definition of their molecular basis.

Topics Covered (Recognized by AI)
Biology99%Medicine98.2%Genetics93.6%Immunology91.9%Internal medicine81%Chemistry76.2%Biochemistry74.5%Immune system66.5%Pathology46.2%Gene37.8%Cell biology35.8%Antigen30.2%Receptor28.7%Antibody26.2%Inflammation24.9%In vitro22.6%Disease22.5%Endocrinology21.4%Cancer research20.3%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

IMMUNOLOGY

Q1
Rank29/183
IndexSCIE
JCISCIE2026

IMMUNOLOGY

Q1
Rank42/183
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF7
Articles / Year7,715
Total Citations4,542
2025
IF5.9
Articles / Year7,027
Total Citations37,734
2024
IF5.7
Articles / Year5,525
Total Citations68,976
2023
IF7.3
Articles / Year6,502
Total Citations133,558
2022
IF8.786
Articles / Year8,221
Total Citations227,287

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #1,498Scopus Q1SCImago Profile
Scopus Coverage:2010-2026
Scopus Broad Areas:Immunology and MicrobiologyMedicine
Scopus Citation Rank (SJR)Q1
1.964

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
6.38

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,792 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations137,387
3-Year Documents20,197
Citable Documents19,337

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)3

Citations in government and international policy documents

Female Author Rate47.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

ImmunologyQ1
Immunology and AllergyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 8.8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
2区IMMUNOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Frontiers in Immunology (abbr: FRONT. IMMUNOL, ISSN: 1664-3224) is a peer-reviewed international scholarly journal in the field of IMMUNOLOGY, published by Frontiers Media S.A. in Switzerland. The periodical holds a Journal Impact Factor (JIF) of 7.00, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.964 (Q1), an H-index of 294.

The journal enforces rigorous peer evaluation with an annual output of approximately 5,759 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,792 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Frontiers Media S.A.
Publication Language
English
Frequency
Periodic
Indexing & Databases
SCIEScopusDOAJPubMed
Editorial Address
AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, SWITZERLAND, CH-1015

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 9879d7db-cbe6-4c1c-a89b-14a109b51ee3
Database Updated: 2026-10-01